Companies /Healthcare

Cardinal Health Inc

NYSE: CAH Medical Distribution
$278.49
▼ $0.76 (−0.27%) today
Markets open · 10:08am ET

24/7 Wall St. View

CAH at a Glance

Valuation
Market cap
$64.5B
P/E ratio
36.1
Dividend yield
0.72%
Profitability
Revenue (TTM)
$257.8B
Profit margin
0.7%
EPS (TTM)
$7.73
Price
52-week range
$180 – $286
24/7 target
$335.40
Street target
$294.87
Earnings
Next report
Feb 3, 2027
Q1 2027 EPS
$3.26
vs. $2.94 est.
+10.9%

Headquartered in Dublin, OH Fiscal year ends June NYSE: CAH cardinalhealth.com

About Cardinal Health

Cardinal Health is a healthcare services and products company. Its largest business distributes branded, specialty and generic pharmaceuticals.

**Pharmaceutical and Specialty Solutions** is by far its largest segment, generating most of revenue. It serves retail pharmacy chains such as CVS Health, with which it recently signed a binding letter of intent to renew distribution agreements. It also serves hospitals and specialty and physician practices, and operates a generics sourcing program.

**Global Medical Products and Distribution** manufactures and distributes medical and laboratory products, including the Cardinal Health Brand line. The company is running an ongoing improvement plan for this segment.

**Other** consists of three operating segments:
- **Nuclear and Precision Health Solutions:** nuclear pharmacies and manufacturing facilities.
- **at-Home Solutions:** home-health and direct-to-patient products and services. The company is expanding this business through the pending acquisition of AdaptHealth's Diabetes Health business.
- **OptiFreight Logistics:** logistics and freight management.

The company also provides performance and data solutions, including real-world evidence research with pharmaceutical partners such as Eli Lilly. Updated

Revenue by Segment · Q1 2027
  1. Pharmaceutical and Specialty Solutions93%
  2. Global Medical Products and Distribution5%
  3. Other3%

Latest Activity

MCKMcKesson
52-week high
$1105.15
+0.21%vs prior 52-week high · Nov 13, 2026

McKesson set another record high at $1,105.15, topping the mark it just made on Nov. 13. Rival Cardinal Health rose 0.97% while customer CVS Health slipped 0.82%.

Before the movelast 24 hours
  1. Jim Cramer
    We just get me into McKesson. Please. Can I just have some Amgen?
Related stockstoday
  • CAHCardinal HealthCompetitor+1.0%
    Jun 30, 2026 · SEC 10-K
  • CVSCVS HealthCustomer-0.8%
    Mar 31, 2026 · SEC 10-K
  • TAKTakeda PharmaceuticalSupplier+0.8%
    Jun 17, 6:06 AM ET · SEC 10-K

Moves: Nov 16, 2026 · Alpha Vantage daily close

5 more related stocks

CAHCardinal Health
52-week high
$283.87
+0.97%vs prior 52-week high · Nov 13, 2026

Cardinal Health notched a fresh one-year high at $283.87, topping the record it set just three sessions earlier. Peers diverged: UnitedHealth added 1.09% while CVS Health slipped 0.82%.

Related stockstoday

Moves: Nov 16, 2026 · Alpha Vantage daily close

6 more related stocks · 4 have no US listing

Now Chief Accounting Officer at CARDINAL HEALTH INC

A new chief accounting officer at the $65.6 billion drug distributor means fresh ownership of the books that govern revenue recognition across one of the largest pharmaceutical supply chains in the US. Her Form 3 starts the clock on future buy and sell disclosures worth tracking.

52-week highs
43stocks hit new 52-week highs this week
  • MSIMotorola Solutions$530.42+7.7%
  • IBNICICI Bank$34.51+7.2%
  • EWEdwards Lifesciences$107.19+6.4%
  • TEVATeva$44.54+5.8%
  • FASTFastenal Company$55.55+4.4%
  • CAHCardinal Health$281.14+4.4%
  • MRNAModerna$223.37+4.1%
  • HUMHumana$450.47+3.9%
  • ICEIntercontinental Exchange$178.49+3.3%
  • KOCoca-Cola Company$99.26+3.3%

43 stocks notched fresh 52-week highs this week, with leadership spread across Motorola Solutions, ICICI Bank, Edwards Lifesciences, Coca-Cola, Humana and Fastenal. Motorola Solutions leads at $530.42, 7.7% past its prior peak.

TAKTakeda Pharmaceutical
52-week high
$21.44
+0.89%vs prior 52-week high · Nov 5, 2026

Takeda's $21.44 close tops the high it set on Nov. 5 by 0.89%, extending a steady climb in the large-cap drugmaker.

Related stockstoday
  • CORCencoraCustomer+2.8%
    Jun 17, 6:06 AM ET · SEC 10-K
  • CAHCardinal HealthCustomer+1.1%
    Mar 31, 2026 · SEC 10-K
  • JNJJohnson & JohnsonPartner+0.9%
    Jun 17, 6:06 AM ET · SEC 10-K

Moves: Nov 13, 2026 · Alpha Vantage daily close

8 more related stocks · 1 has no US listing

Biggest movers · On the open
  • APPAppLovin$351.85+29.5%
  • VERXVertex$18.06+13.4%
  • TMToyota$218.6+9.6%
  • SONYSony Group$28.18+8.7%
  • CAHCardinal Health$283.59+8.2%
  • BROSDutch Bros$37.27-15.1%
  • MELIMercadoLibre$1,537.88-11.6%
  • BEBloom Energy$177.57-11.4%
  • ASXASE Technology Holding$33.24-11.3%
  • CAVACava$55.22-10.6%

AppLovin opened up 29.5%, the single biggest move across 382 priority names and nearly double the next gainer. The downside is just as wide, with Dutch Bros off 15.1% and four more names down double digits.

CAHCardinal Health
Q1 2027
EPS
$3.26
est $2.94+10.9%
Revenue
$67.51B
est $66.51B+1.5%

Full-year guidance went up to $12.80 to $13.00 per share, and management locked in a binding letter of intent to renew its CVS Health distribution agreements, removing the biggest customer-concentration question hanging over the stock. Pharmaceutical and Specialty Solutions profit rose 17%, the fourth straight quarter of beating EPS expectations.

Quarterly EPS — reported vs estimate
Given this quarter's strong performance and our updated expectations for the remainder of the year, we are raising our fiscal 2027 non-GAAP EPS outlook.

A guidance raise one quarter into fiscal 2027 sets a higher bar for the rest of the year at the $60.7 billion distributor, and it puts pressure on rival wholesalers reporting into the same demand backdrop. Watch how much of the raise management attributes to the quarter versus the back half.

CAHCardinal Health
New 52-week high$262.01+1.7% vs prior high · 2026-10-20

Cardinal Health cleared $262.01, a fresh 52-week high, 1.73% above the peak it set on October 20. The drug distributor keeps grinding to new records.

CAHCardinal Health
New 52-week high$253.71+2.0% vs prior high · 2026-09-03

Cardinal Health closed at $253.71, a record that clears its early September peak by 2.05% and caps a climb from $154.58 a year ago. The $58.7 billion distributor has now taken out every high set during its spring stall.

CAH Coverage

11:45am ET
Investing

Why Cardinal Health May Be a Best Buy for the Coming Stagflation

This morning’s jobs report landed hard. Nonfarm payrolls plunged by 92,000 jobs, shattering expectations of a 55,000 gain. Unemployment climbed to 4.4%, while average hourly earnings jumped 0.4% month-over-month — well above…

CAH
Rich Duprey

Frequently Asked Questions

What does Cardinal Health do?

Cardinal Health is a healthcare services and products company. Its largest business distributes branded, specialty and generic pharmaceuticals. **Pharmaceutical and Specialty Solutions** is by far its largest segment, generating most of revenue.

What is the CAH stock price target?

24/7 Wall St.'s 12-month price target for CAH is $335.40, rated Buy. The Wall Street consensus target is $294.87. CAH price prediction →